Hydrogen Research Study
← Back to Research Library
Other source-grounded researchOther Researchinhaled hydrogen gas

Gas as medicine: the case for hydrogen gas as a therapeutic agent for critical illness.

Lakhmir S Chawla · Intensive care medicine experimental · 2025

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Oxidative Stress and Antioxidant Signaling
Evidence type Other source-grounded research
Publication type Other Research
Hydrogen method inhaled hydrogen gas

H2HUBB TAKEAWAY

Molecular hydrogen gas (HG), administered through inhalation or as hydrogen-rich fluids (HRF), has demonstrated antioxidant, anti-inflammatory, antiapoptotic, cytoprotective, and beneficial mitochondrial effects in critical illness. This source-grounded publication contributes evidence relevant to molecular hydrogen and is retained in a transparent general research category when a more specific study design is not supported by the indexed record.

What the Findings Mean

H2HUBB reviewed how inhaled hydrogen gas was evaluated in this publication and summarizes the source-grounded findings below. Preclinical studies and human clinical studies consistently endorse hydrogen gas as safe, with mechanisms of action linked to vital molecular pathways, such as reductions in both oxidative stress and inflammation with beneficial effects on mitochondria.

What Effects Did Molecular Hydrogen Have?

Given the lack of therapeutic options for many patients with severe critical illness, clinical trials should be initiated to fully explore the therapeutic benefits of hydrogen gas in these life-threatening conditions. Preclinical studies and human clinical studies consistently endorse hydrogen gas as safe, with mechanisms of action linked to vital molecular pathways, such as reductions in both oxidative stress and inflammation with beneficial effects on mitochondria. The authors concluded that hG treatment delivered by inhalation and/or HRF have been shown promise across a wide array of critical conditions, such as organ injury, sepsis, ARDS, and AKI. Molecular hydrogen gas (HG), administered through inhalation or as hydrogen-rich fluids (HRF), has demonstrated antioxidant, anti-inflammatory, antiapoptotic, cytoprotective, and beneficial mitochondrial effects in critical illness.

Why These Findings Matter

These findings add evidence supporting molecular hydrogen's therapeutic potential within the biological process and outcomes directly measured in this publication and contribute to the growing body of molecular-hydrogen research.

How Strong Is This Evidence?

H2HUBB classifies this publication as other research and interprets only the outcomes directly supported by the source record.

Technical Study Details

H2HUBB classifies this publication as other research with other supported evidence. The hydrogen delivery method was inhaled hydrogen gas.

Limitations and Safety

No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.

Original Study and H2HUBB Research Context

H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.

What the Researchers Studied

The available source identifies this publication as other research. A more specific population or model was not separately reported in the source text available to H2HUBB.